R
RxSight, Inc.
RXST · NASDAQ · Healthcare · 285M
Closing price
$4.81
-0.82% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.7×
Enterprise value / EBITDAEV/EBITDA
-4.9×
Free cash flow yieldFCF yield
-9.8%
Return on equityROE
-14.1%
Operating margin
-35.8%
Net debt / EBITDAbalance-sheet strength
0.2×
Interest coverage
-1204.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.